InVivoSIM anti-human PD-1 (Pembrolizumab Biosimilar)
SIM0010
Overview
- SupplierBio X Cell
- Product NameInVivoSIM anti-human PD-1 (Pembrolizumab Biosimilar)
- Delivery Days Customer7
- ApplicationsFunctional Assay, Neutralisation/Blocking
- CertificationResearch Use Only
- ClonalityMonoclonal
- Clone IDPembrolizumab
- Concentration4-11 mg/ml
- Estimated Purity>95%
- HostHuman
- IsotypeIgG4
- Storage Instruction2°C to 8°C
- UNSPSC12352203
References
- Targeting PD-L1 in solid cancer with myeloid cells expressing a CAR-like immune receptor.Read more
- ADCY4 promotes brain metastasis in small cell lung cancer and is associated with energy metabolism.Read more
- A CRISPR activation screen identifies MUC-21 as critical for resistance to NK and T cell-mediated cytotoxicity.Read more
- NR4A1 mediates NK-cell dysfunction in hepatocellular carcinoma via the IFN-gamma/p-STAT1/IRF1 pathway.Read more
- Anti-tumor effects of anti-PD-1 antibody, pembrolizumab, in humanized NSG PDX mice xenografted with dedifferentiated liposarcoma.Read more